Abstract | INTRODUCTION: AREAS COVERED: The authors provide a comprehensive review on the cellular and molecular biology of kinins and their receptors is delineated along with evolution and discovery of selective peptide and non- peptide antagonists. The authors describe the in vitro and in vivo methods used to understand the relative functional roles of B(1)R and B(2)R in physiology and pathohysiology. Furthermore, the authors translate the evaluation of kinin antagonists in selected preclinical models and associated clinical indications. Literature was surveyed from original publications, standard sources, SciFinder, patent applications and clinical trials. EXPERT OPINION: The authors suggest that several key areas of functional biology need consideration, namely: re-evaluation, particularly in vivo, of the mechanism of action and relative functional roles of the B(1)R and B(2)R in physiology and acute and chronic disease in animals and man; need for improved animal models with increased use of humanized and human systems; development of fluorescent probes for use in vivo in animals and man using advanced imaging techniques; combination of kinin receptor antagonists and traditional chemotherapy for various cancers.
|
Authors | Eric T Whalley, Carlos D Figueroa, Lajos Gera, Kanti D Bhoola |
Journal | Expert opinion on drug discovery
(Expert Opin Drug Discov)
Vol. 7
Issue 12
Pg. 1129-48
(Dec 2012)
ISSN: 1746-045X [Electronic] England |
PMID | 23095011
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
|
Chemical References |
- Antineoplastic Agents
- Bradykinin B1 Receptor Antagonists
- Bradykinin B2 Receptor Antagonists
- Kinins
|
Topics |
- Animals
- Antineoplastic Agents
(pharmacology)
- Bradykinin B1 Receptor Antagonists
- Bradykinin B2 Receptor Antagonists
- Drug Discovery
- Humans
- Kinins
(physiology)
- Models, Animal
- Neoplasms
(drug therapy)
|